Physician profile
Cheryl Buda
NPI 1497852511
$1,452.71
in general payments reported to CMS, 2019-2025
20 companies · $37.59 in 2025
The $37.59 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $260 · 2021: $59.90 · 2022: $125 · 2023: $43.44 · 2024: $119 · 2025: $37.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $371.35 | 2019-2022 | |
| Allergan, INC. | $160.22 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $147.54 | 2019-2020 | |
| Abbvie INC. | $87.30 | 2021-2025 | |
| Lundbeck LLC | $86.69 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.33 | 2021-2024 | Caplyta |
| Shire North American Group INC | $69.89 | 2019 | |
| Neurocrine Biosciences, INC. | $60.17 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $54.12 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $50.72 | 2019-2020 | |
| Itamar Medical INC | $43.44 | 2023 | Watchpatone |
| Vertical Pharmaceuticals, LLC | $39.70 | 2019-2020 | |
| Neos Therapeutics, Lp | $35.20 | 2020 | |
| Noven Therapeutics, LLC | $30.65 | 2024 | Xelstrym, Secuado |
| Janssen Pharmaceuticals, INC | $30.54 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $29.98 | 2020 | |
| Vanda Pharmaceuticals INC. | $29.39 | 2020-2025 | Fanapt |
| Jazz Pharmaceuticals INC. | $14.80 | 2019 | |
| Tris Pharma INC | $14.48 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Buda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.